M&A Deal Summary

eMed Acquires Babylon

On September 4, 2023, eMed acquired healthcare services company Babylon

Acquisition Highlights
  • This is eMed’s 1st transaction in the Healthcare Services sector.
  • This is eMed’s 1st transaction in the United Kingdom.

M&A Deal Summary

Date 2023-09-04
Target Babylon
Sector Healthcare Services
Buyer(s) eMed
Deal Type Special Situations/Distressed

Target

Babylon

London, United Kingdom
Babylon is a globally-leading technology company that combines technology and medical expertise to bring doctors and people closer together, with digital health tools designed to empower people with knowledge about their health. Through a range of digital health services such as an AI-backed app and video doctor appointments provide around-the-clock access to affordable, holistic healthcare services and information. Babylon work with governments, health providers and insurers across the globe, and healthcare facilities from small local practices to large hospitals. Babylon was incorporated in 2013 and is based in London, United Kingdom.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

eMed

Miami, Florida, United States

Category Company
Sector Consumer Services
DESCRIPTION

eMed provides at-home healthcare testing and supervising services by using its digital point-of-care platform. It embraces quantitative medicine to deliver prescribed tests and treatments directly to patients, driving better and more cost-effective results. eMed is based in Miami, Florida.


DEAL STATS #
Overall 1 of 2
Sector (Healthcare Services) 1 of 1
Type (Special Situations/Distressed) 1 of 1
Country (United Kingdom) 1 of 1
Year (2023) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-01-29 Science 37

Research Triangle Park, North Carolina, United States

Science 37 provides clinical research by enabling universal trial access for patients. As a single Metasite, the company reaches an expanded patient population beyond the traditional site and delivers the recruiting power of up to 20 sites in one with greater patient diversity. Science 37 was founded in 2014 and is based in Research Triangle Park, North Carolina.

Buy $38M